Comparison of Sclerotherapy Agents Used for Rectal Prolapse Treatment in Children
NCT ID: NCT06353230
Last Updated: 2024-04-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
93 participants
INTERVENTIONAL
2019-10-15
2021-04-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Laparoscopic Suture Versus Mesh Rectopexy for the Treatment of Persistent Complete Rectal Prolapse in Children
NCT04117633
Cap-assisted Endoscopic Sclerotherapy for Internal Hemorrhoids and Rectal Prolapse
NCT03917056
Pathologic Assessment of Rectal Prolapse in the Young
NCT03012464
Preliminary Results of Laparoscopic Assisted Transanal Proximal Rectosigmoidectomy Combined With Malone Antegrade Continence Enema for the Management of Intractable Functional Constipation in Children
NCT07180680
Fat Injection for Rectocele Treatment: A Novel Approach
NCT06604702
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A with 5% phenol in almond oil
Group A patients with rectal prolapse were given injection sclerotherapy with 5% phenol in almond oil,
injection 5% phenol in almond oil
Group A were given 5% phenol in almond oil
injection 15% hypertonic saline
Group B were given hypertonic saline
injection 50% dextrose water
group C were given 50% dextrose water
Group B with hypertonic saline
Group B with rectal prolapse were given injection sclerotherapy with 15% hypertonic saline
injection 5% phenol in almond oil
Group A were given 5% phenol in almond oil
injection 15% hypertonic saline
Group B were given hypertonic saline
injection 50% dextrose water
group C were given 50% dextrose water
Group C with 50% Dextrose water
Group C with rectal prolapse were given injection sclerotherapy with 50% Dextrose water
injection 5% phenol in almond oil
Group A were given 5% phenol in almond oil
injection 15% hypertonic saline
Group B were given hypertonic saline
injection 50% dextrose water
group C were given 50% dextrose water
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
injection 5% phenol in almond oil
Group A were given 5% phenol in almond oil
injection 15% hypertonic saline
Group B were given hypertonic saline
injection 50% dextrose water
group C were given 50% dextrose water
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients with previous history of surgery on pelvic floor documented in medical record.
* Caudaequina syndrome, neural tube defects, Sacrococcygeal teratoma, Hirschsprung,s disease, congenitalmega colon and rectal polyps documented in medical record. -
3 Years
13 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
King Edward Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Muhammad Sharif
PROFESSOR
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
department of pediatric surgery King Edward Medical University
Lahore, Punjab Province, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.